-+ 0.00%
-+ 0.00%
-+ 0.00%

Terns Pharmaceuticals Showcases TERN-701 as Potential Best-in-Disease Therapy for CML in New Corporate Presentation

Reuters·01/12/2026 13:13:26

Please log in to view news